What is Net Income?

Net income, often called the bottom line, is the total profit remaining after all expenses have been subtracted from total revenue. This includes cost of goods sold, operating expenses, interest expense, taxes, depreciation, amortization, and any other charges. Net income appears at the bottom of the income statement and represents the ultimate measure of a company's profitability for a given period.

Net income is reported on both a GAAP (Generally Accepted Accounting Principles) and non-GAAP (adjusted) basis. GAAP net income includes all charges and credits, including one-time items like asset impairments, restructuring costs, and gains or losses on investments. Adjusted net income excludes these items to provide a clearer picture of ongoing operational performance. Both measures have value, and investors should understand what is included in each.

For cannabis companies, net income is heavily impacted by Section 280E, which prevents deduction of operating expenses from taxable income. This means many cannabis companies that generate positive operating income still report negative or severely depressed net income because of the outsized tax burden. Understanding the pre-280E and post-280E profitability picture is essential for accurately evaluating cannabis company performance.

Positive net income is a milestone that many cannabis companies have not yet achieved. Companies that demonstrate a clear trajectory from net losses toward profitability are often rewarded with higher stock valuations, as the market anticipates the eventual inflection point. Consistent quarterly improvement in net income, even if still negative, is generally viewed more favorably than volatile swings between profit and loss.

When analyzing net income for cannabis stocks, investors must account for industry-specific factors that can distort this metric compared to other sectors. Section 280E tax treatment dramatically impacts profitability metrics for US plant-touching operators, potentially making profitable companies appear unprofitable on paper. Additionally, the rapid growth phase of the cannabis industry means that historical comparisons within the sector itself may be limited.

Cannabis companies often report both GAAP and adjusted financial figures, and net income may differ significantly between the two. Investors should understand which version is being presented and what adjustments have been made. Comparing net income across cannabis sub-sectors (MSOs vs. LPs vs. ancillary companies) requires additional context because each faces different regulatory environments, tax treatments, and competitive dynamics.